| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospitalization | 69 | 2022 | 831 | 5.990 |
Why?
|
| United States | 102 | 2022 | 3922 | 2.130 |
Why?
|
| Accidents, Traffic | 6 | 2018 | 15 | 1.880 |
Why?
|
| Postoperative Complications | 7 | 2016 | 99 | 1.870 |
Why?
|
| Humans | 142 | 2026 | 17622 | 1.720 |
Why?
|
| Arthroplasty, Replacement, Knee | 4 | 2021 | 17 | 1.560 |
Why?
|
| Emergency Service, Hospital | 10 | 2017 | 402 | 1.540 |
Why?
|
| Hospital Costs | 10 | 2018 | 37 | 1.530 |
Why?
|
| Ambulatory Surgical Procedures | 5 | 2015 | 7 | 1.520 |
Why?
|
| Male | 88 | 2026 | 10014 | 1.430 |
Why?
|
| Female | 96 | 2026 | 12715 | 1.400 |
Why?
|
| Rotavirus Infections | 15 | 2019 | 33 | 1.370 |
Why?
|
| Rotavirus Vaccines | 13 | 2019 | 53 | 1.250 |
Why?
|
| Middle Aged | 59 | 2026 | 7954 | 1.230 |
Why?
|
| Aged | 50 | 2026 | 6223 | 1.160 |
Why?
|
| Child, Preschool | 55 | 2019 | 1455 | 1.130 |
Why?
|
| Infant | 54 | 2019 | 1228 | 1.120 |
Why?
|
| Mandatory Reporting | 2 | 2018 | 3 | 1.100 |
Why?
|
| Adult | 60 | 2025 | 7621 | 1.090 |
Why?
|
| Patient Readmission | 7 | 2017 | 163 | 1.070 |
Why?
|
| Length of Stay | 18 | 2016 | 182 | 1.040 |
Why?
|
| Brain Injuries | 4 | 2010 | 14 | 1.000 |
Why?
|
| Patient Discharge | 9 | 2021 | 154 | 0.980 |
Why?
|
| Health Services Research | 8 | 2016 | 201 | 0.960 |
Why?
|
| Adolescent | 46 | 2019 | 3625 | 0.960 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2023 | 540 | 0.960 |
Why?
|
| Retrospective Studies | 24 | 2026 | 2502 | 0.960 |
Why?
|
| Arthroplasty, Replacement, Hip | 3 | 2021 | 10 | 0.940 |
Why?
|
| Aged, 80 and over | 31 | 2026 | 1976 | 0.930 |
Why?
|
| Wounds and Injuries | 3 | 2016 | 43 | 0.900 |
Why?
|
| Text Messaging | 2 | 2026 | 38 | 0.870 |
Why?
|
| Young Adult | 36 | 2019 | 2538 | 0.870 |
Why?
|
| Hysterectomy | 4 | 2016 | 30 | 0.870 |
Why?
|
| Databases, Factual | 18 | 2018 | 304 | 0.850 |
Why?
|
| Respiratory Syncytial Virus Infections | 8 | 2019 | 37 | 0.850 |
Why?
|
| Indians, North American | 10 | 2015 | 48 | 0.840 |
Why?
|
| Child | 40 | 2019 | 2485 | 0.780 |
Why?
|
| Motorcycles | 4 | 2010 | 5 | 0.740 |
Why?
|
| Incidence | 30 | 2022 | 1278 | 0.740 |
Why?
|
| Influenza, Human | 8 | 2022 | 294 | 0.730 |
Why?
|
| Bariatric Surgery | 4 | 2009 | 133 | 0.720 |
Why?
|
| Ambulatory Care Facilities | 3 | 2016 | 64 | 0.700 |
Why?
|
| Appointments and Schedules | 2 | 2021 | 23 | 0.700 |
Why?
|
| Automobile Driving | 2 | 2018 | 10 | 0.700 |
Why?
|
| Age Factors | 19 | 2019 | 874 | 0.670 |
Why?
|
| Reminder Systems | 1 | 2021 | 76 | 0.640 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 7 | 2012 | 18 | 0.630 |
Why?
|
| Telephone | 1 | 2021 | 159 | 0.620 |
Why?
|
| Infant, Newborn | 32 | 2019 | 842 | 0.620 |
Why?
|
| Gastroenteritis | 8 | 2018 | 16 | 0.610 |
Why?
|
| Insurance Coverage | 6 | 2012 | 99 | 0.600 |
Why?
|
| Ambulatory Care | 4 | 2019 | 228 | 0.570 |
Why?
|
| Delivery of Health Care | 2 | 2021 | 383 | 0.570 |
Why?
|
| Hypertension | 1 | 2023 | 486 | 0.550 |
Why?
|
| Surgical Procedures, Operative | 2 | 2016 | 16 | 0.540 |
Why?
|
| Physician's Role | 1 | 2018 | 26 | 0.540 |
Why?
|
| International Classification of Diseases | 2 | 2016 | 85 | 0.540 |
Why?
|
| Inpatients | 6 | 2017 | 78 | 0.540 |
Why?
|
| Ascites | 1 | 2017 | 1 | 0.510 |
Why?
|
| Protein-Energy Malnutrition | 1 | 2017 | 3 | 0.510 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2017 | 5 | 0.510 |
Why?
|
| Pressure Ulcer | 1 | 2016 | 5 | 0.500 |
Why?
|
| Internationality | 1 | 2016 | 13 | 0.490 |
Why?
|
| Robotic Surgical Procedures | 1 | 2016 | 8 | 0.480 |
Why?
|
| Head Protective Devices | 3 | 2010 | 4 | 0.480 |
Why?
|
| Quality of Life | 3 | 2021 | 505 | 0.470 |
Why?
|
| Medicare | 7 | 2021 | 197 | 0.470 |
Why?
|
| Hospital Mortality | 8 | 2017 | 135 | 0.460 |
Why?
|
| Dementia | 1 | 2018 | 136 | 0.450 |
Why?
|
| Laparoscopy | 4 | 2016 | 46 | 0.440 |
Why?
|
| Mind-Body Therapies | 2 | 2014 | 8 | 0.440 |
Why?
|
| Medicaid | 6 | 2017 | 188 | 0.430 |
Why?
|
| Cross-Sectional Studies | 13 | 2017 | 1295 | 0.430 |
Why?
|
| Communicable Diseases | 5 | 2016 | 15 | 0.420 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2016 | 368 | 0.420 |
Why?
|
| Seasons | 13 | 2018 | 116 | 0.420 |
Why?
|
| Surgical Wound Infection | 1 | 2014 | 4 | 0.420 |
Why?
|
| Robotics | 1 | 2014 | 5 | 0.410 |
Why?
|
| Insurance, Health | 6 | 2017 | 169 | 0.410 |
Why?
|
| Anemia, Sickle Cell | 2 | 2011 | 7 | 0.410 |
Why?
|
| Prostatectomy | 1 | 2014 | 75 | 0.400 |
Why?
|
| Diarrhea | 7 | 2018 | 10 | 0.390 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2013 | 7 | 0.390 |
Why?
|
| Intention | 1 | 2013 | 28 | 0.390 |
Why?
|
| Quality of Health Care | 3 | 2012 | 260 | 0.380 |
Why?
|
| Comparative Effectiveness Research | 1 | 2013 | 59 | 0.370 |
Why?
|
| Inuits | 4 | 2014 | 9 | 0.350 |
Why?
|
| Rotavirus | 5 | 2019 | 17 | 0.350 |
Why?
|
| Fatigue | 2 | 2014 | 30 | 0.350 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 262 | 0.340 |
Why?
|
| Social Support | 1 | 2013 | 215 | 0.340 |
Why?
|
| Health Expenditures | 3 | 2009 | 72 | 0.340 |
Why?
|
| Patient Admission | 5 | 2016 | 69 | 0.340 |
Why?
|
| Risk Assessment | 8 | 2022 | 1093 | 0.330 |
Why?
|
| Hospitals, Community | 5 | 2017 | 23 | 0.330 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2002 | 308 | 0.320 |
Why?
|
| Time Factors | 8 | 2017 | 1038 | 0.300 |
Why?
|
| Pneumonia, Pneumococcal | 3 | 2015 | 13 | 0.300 |
Why?
|
| Managed Care Programs | 4 | 2012 | 300 | 0.290 |
Why?
|
| Obesity | 4 | 2009 | 821 | 0.290 |
Why?
|
| Intussusception | 3 | 2016 | 16 | 0.290 |
Why?
|
| Multiple Sclerosis | 1 | 2010 | 102 | 0.280 |
Why?
|
| Logistic Models | 8 | 2016 | 866 | 0.280 |
Why?
|
| Technology Assessment, Biomedical | 3 | 1997 | 6 | 0.280 |
Why?
|
| Age Distribution | 12 | 2018 | 230 | 0.280 |
Why?
|
| Sepsis | 2 | 2019 | 64 | 0.280 |
Why?
|
| Colorado | 3 | 2026 | 170 | 0.280 |
Why?
|
| Pacemaker, Artificial | 1 | 2008 | 2 | 0.270 |
Why?
|
| Defibrillators, Implantable | 1 | 2008 | 29 | 0.270 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2008 | 30 | 0.270 |
Why?
|
| Severity of Illness Index | 5 | 2016 | 446 | 0.270 |
Why?
|
| Myocardial Infarction | 2 | 2022 | 226 | 0.270 |
Why?
|
| Disabled Persons | 1 | 2008 | 35 | 0.270 |
Why?
|
| Depression | 3 | 2014 | 507 | 0.270 |
Why?
|
| Treatment Outcome | 7 | 2016 | 1161 | 0.260 |
Why?
|
| Sex Factors | 8 | 2016 | 599 | 0.260 |
Why?
|
| Pandemics | 3 | 2023 | 295 | 0.260 |
Why?
|
| Health Services | 2 | 2016 | 110 | 0.260 |
Why?
|
| Pneumonia | 3 | 2016 | 48 | 0.250 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 642 | 0.250 |
Why?
|
| Chronic Disease | 1 | 2009 | 398 | 0.250 |
Why?
|
| Insurance Claim Reporting | 1 | 2006 | 6 | 0.250 |
Why?
|
| Alaska Natives | 2 | 2016 | 5 | 0.240 |
Why?
|
| Postural Balance | 1 | 2026 | 14 | 0.240 |
Why?
|
| Respiratory Tract Infections | 4 | 2015 | 59 | 0.240 |
Why?
|
| Accidental Falls | 1 | 2026 | 50 | 0.240 |
Why?
|
| Follow-Up Studies | 5 | 2021 | 1157 | 0.240 |
Why?
|
| Unemployment | 1 | 2025 | 12 | 0.230 |
Why?
|
| Comorbidity | 5 | 2019 | 552 | 0.230 |
Why?
|
| Cat-Scratch Disease | 1 | 2005 | 1 | 0.230 |
Why?
|
| Exercise Therapy | 1 | 2026 | 75 | 0.230 |
Why?
|
| Health Literacy | 1 | 2025 | 38 | 0.230 |
Why?
|
| Blastomycosis | 2 | 2015 | 2 | 0.220 |
Why?
|
| Leiomyoma | 2 | 2002 | 14 | 0.220 |
Why?
|
| Alaska | 9 | 2016 | 16 | 0.220 |
Why?
|
| Private Sector | 2 | 2002 | 15 | 0.220 |
Why?
|
| Sex Distribution | 8 | 2018 | 174 | 0.210 |
Why?
|
| Synostosis | 1 | 2004 | 1 | 0.210 |
Why?
|
| Tarsal Bones | 1 | 2004 | 1 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2004 | 3 | 0.210 |
Why?
|
| Carpal Bones | 1 | 2004 | 3 | 0.210 |
Why?
|
| Spine | 1 | 2004 | 8 | 0.210 |
Why?
|
| Trauma Severity Indices | 2 | 2016 | 6 | 0.210 |
Why?
|
| Health Care Surveys | 4 | 2017 | 210 | 0.210 |
Why?
|
| Hospitals, Urban | 4 | 2016 | 11 | 0.210 |
Why?
|
| Data Collection | 3 | 2013 | 234 | 0.200 |
Why?
|
| Asthma | 2 | 2019 | 401 | 0.200 |
Why?
|
| Child, Hospitalized | 2 | 2003 | 15 | 0.200 |
Why?
|
| Vaccination | 4 | 2019 | 726 | 0.200 |
Why?
|
| Health Care Costs | 5 | 2014 | 211 | 0.200 |
Why?
|
| Hospitals | 3 | 2014 | 71 | 0.200 |
Why?
|
| Regression Analysis | 3 | 2016 | 268 | 0.190 |
Why?
|
| Subacute Care | 2 | 2021 | 3 | 0.190 |
Why?
|
| Probability | 2 | 2016 | 70 | 0.190 |
Why?
|
| Wounds, Gunshot | 1 | 2003 | 18 | 0.190 |
Why?
|
| Health Promotion | 1 | 2025 | 293 | 0.190 |
Why?
|
| Venous Thrombosis | 1 | 2022 | 23 | 0.180 |
Why?
|
| Public Health Informatics | 1 | 2002 | 7 | 0.180 |
Why?
|
| Public Sector | 1 | 2002 | 7 | 0.180 |
Why?
|
| Database Management Systems | 1 | 2002 | 14 | 0.180 |
Why?
|
| Prevalence | 9 | 2019 | 830 | 0.180 |
Why?
|
| Pulmonary Embolism | 1 | 2022 | 46 | 0.180 |
Why?
|
| Endometrium | 1 | 2002 | 3 | 0.180 |
Why?
|
| Menorrhagia | 1 | 2002 | 3 | 0.180 |
Why?
|
| Catheter Ablation | 1 | 2002 | 11 | 0.180 |
Why?
|
| Skilled Nursing Facilities | 1 | 2021 | 6 | 0.180 |
Why?
|
| Mastectomy | 1 | 2001 | 34 | 0.170 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 163 | 0.170 |
Why?
|
| Disease Outbreaks | 4 | 2009 | 37 | 0.170 |
Why?
|
| Blood Pressure | 1 | 2023 | 288 | 0.170 |
Why?
|
| Insurance Claim Review | 2 | 2012 | 49 | 0.170 |
Why?
|
| Medically Uninsured | 6 | 2017 | 41 | 0.170 |
Why?
|
| Epidemics | 2 | 2018 | 4 | 0.160 |
Why?
|
| Heart Failure | 2 | 2016 | 414 | 0.160 |
Why?
|
| Physician Executives | 2 | 1997 | 4 | 0.160 |
Why?
|
| Knee Joint | 1 | 2020 | 2 | 0.160 |
Why?
|
| Physical Therapy Modalities | 1 | 2020 | 3 | 0.160 |
Why?
|
| Health Care Rationing | 2 | 2002 | 11 | 0.160 |
Why?
|
| Cost of Illness | 2 | 2014 | 92 | 0.160 |
Why?
|
| Hospital Charges | 4 | 2008 | 7 | 0.160 |
Why?
|
| Physicians | 2 | 2018 | 120 | 0.150 |
Why?
|
| Respiratory Syncytial Virus, Human | 3 | 2015 | 26 | 0.150 |
Why?
|
| Health Status Disparities | 2 | 2011 | 151 | 0.150 |
Why?
|
| Population Groups | 2 | 2016 | 7 | 0.150 |
Why?
|
| Bacterial Infections | 1 | 2019 | 6 | 0.150 |
Why?
|
| Bacteria | 1 | 2019 | 9 | 0.150 |
Why?
|
| Multivariate Analysis | 3 | 2012 | 527 | 0.150 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2019 | 16 | 0.150 |
Why?
|
| Physician Incentive Plans | 1 | 1999 | 4 | 0.150 |
Why?
|
| Denmark | 2 | 2016 | 19 | 0.150 |
Why?
|
| Hedgehog Proteins | 1 | 2018 | 2 | 0.150 |
Why?
|
| Sarcoidosis | 1 | 2018 | 2 | 0.150 |
Why?
|
| Intestines | 1 | 2018 | 5 | 0.150 |
Why?
|
| Health Communication | 1 | 2019 | 16 | 0.150 |
Why?
|
| African Americans | 3 | 2018 | 429 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2018 | 17 | 0.140 |
Why?
|
| Medical Oncology | 1 | 2019 | 33 | 0.140 |
Why?
|
| Licensure | 1 | 2018 | 4 | 0.140 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 143 | 0.140 |
Why?
|
| Laser Therapy | 2 | 1997 | 2 | 0.140 |
Why?
|
| Risk | 2 | 2022 | 492 | 0.140 |
Why?
|
| Seizures | 1 | 2018 | 28 | 0.140 |
Why?
|
| Disease Transmission, Infectious | 1 | 2018 | 12 | 0.140 |
Why?
|
| Intensive Care Units | 1 | 1999 | 105 | 0.130 |
Why?
|
| Hospitals, Rural | 2 | 2016 | 6 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 152 | 0.130 |
Why?
|
| Poison Control Centers | 2 | 2008 | 3 | 0.130 |
Why?
|
| Poisoning | 2 | 2008 | 6 | 0.130 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2017 | 10 | 0.130 |
Why?
|
| Health Personnel | 1 | 2019 | 135 | 0.130 |
Why?
|
| Decision Making, Organizational | 1 | 1997 | 3 | 0.130 |
Why?
|
| Diagnosis-Related Groups | 5 | 2016 | 19 | 0.130 |
Why?
|
| Survivors | 2 | 2016 | 157 | 0.130 |
Why?
|
| Smoke-Free Policy | 1 | 2016 | 6 | 0.120 |
Why?
|
| Physician-Patient Relations | 2 | 2016 | 168 | 0.120 |
Why?
|
| Greece | 1 | 2016 | 1 | 0.120 |
Why?
|
| Spain | 1 | 2016 | 5 | 0.120 |
Why?
|
| Iatrogenic Disease | 1 | 2016 | 8 | 0.120 |
Why?
|
| Government Agencies | 1 | 2016 | 5 | 0.120 |
Why?
|
| Patient Selection | 2 | 2014 | 181 | 0.120 |
Why?
|
| Linear Models | 4 | 2008 | 204 | 0.120 |
Why?
|
| Canada | 1 | 2016 | 54 | 0.120 |
Why?
|
| Death Certificates | 2 | 2013 | 17 | 0.120 |
Why?
|
| Internet | 1 | 2018 | 207 | 0.120 |
Why?
|
| Nurse-Patient Relations | 1 | 2016 | 8 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2017 | 380 | 0.120 |
Why?
|
| Pneumococcal Infections | 2 | 2013 | 43 | 0.120 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2016 | 19 | 0.120 |
Why?
|
| Candidiasis | 1 | 2016 | 1 | 0.120 |
Why?
|
| Decision Making | 2 | 2014 | 177 | 0.120 |
Why?
|
| Risk Factors | 10 | 2017 | 3291 | 0.120 |
Why?
|
| Social Class | 1 | 2016 | 117 | 0.120 |
Why?
|
| Cross Infection | 1 | 2016 | 24 | 0.120 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 702 | 0.120 |
Why?
|
| Focus Groups | 1 | 2016 | 144 | 0.120 |
Why?
|
| Propensity Score | 1 | 2016 | 80 | 0.120 |
Why?
|
| Economic Competition | 2 | 2014 | 2 | 0.120 |
Why?
|
| Antibodies, Viral | 2 | 2015 | 73 | 0.120 |
Why?
|
| Preventive Health Services | 1 | 2017 | 147 | 0.120 |
Why?
|
| Topography, Medical | 1 | 2015 | 5 | 0.110 |
Why?
|
| Chemoprevention | 1 | 2015 | 12 | 0.110 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 2 | 2013 | 56 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 25 | 0.110 |
Why?
|
| Emergency Medical Services | 2 | 2017 | 44 | 0.110 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2014 | 4 | 0.110 |
Why?
|
| Environment | 1 | 2015 | 50 | 0.110 |
Why?
|
| Communication | 1 | 2016 | 181 | 0.110 |
Why?
|
| Breast Neoplasms | 2 | 2005 | 1005 | 0.110 |
Why?
|
| Leptospirosis | 1 | 2014 | 1 | 0.110 |
Why?
|
| State Government | 2 | 2006 | 14 | 0.110 |
Why?
|
| Meningococcal Infections | 1 | 2014 | 17 | 0.110 |
Why?
|
| Double-Blind Method | 2 | 2013 | 144 | 0.110 |
Why?
|
| Mindfulness | 1 | 2014 | 30 | 0.100 |
Why?
|
| Technology Transfer | 1 | 2014 | 1 | 0.100 |
Why?
|
| Encephalitis | 1 | 2014 | 4 | 0.100 |
Why?
|
| Smoking | 1 | 2016 | 420 | 0.100 |
Why?
|
| Carrier State | 1 | 2013 | 8 | 0.100 |
Why?
|
| Health Services Needs and Demand | 3 | 2016 | 88 | 0.100 |
Why?
|
| Chickenpox | 1 | 2014 | 35 | 0.100 |
Why?
|
| Food, Fortified | 1 | 2013 | 5 | 0.100 |
Why?
|
| Milk | 1 | 2013 | 8 | 0.100 |
Why?
|
| Chickenpox Vaccine | 1 | 2014 | 91 | 0.100 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2013 | 1 | 0.100 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 24 | 0.100 |
Why?
|
| Endovascular Procedures | 1 | 2013 | 6 | 0.100 |
Why?
|
| Risk Adjustment | 2 | 2012 | 19 | 0.100 |
Why?
|
| United States Indian Health Service | 4 | 2015 | 7 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 120 | 0.100 |
Why?
|
| Vitamin D | 1 | 2013 | 76 | 0.090 |
Why?
|
| Catastrophic Illness | 1 | 2012 | 1 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2015 | 2502 | 0.090 |
Why?
|
| Models, Biological | 1 | 2012 | 27 | 0.090 |
Why?
|
| Capitation Fee | 1 | 2012 | 10 | 0.090 |
Why?
|
| Fee-for-Service Plans | 1 | 2012 | 21 | 0.090 |
Why?
|
| Medicare Part C | 1 | 2012 | 11 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 545 | 0.090 |
Why?
|
| Confidence Intervals | 4 | 2012 | 228 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2010 | 137 | 0.090 |
Why?
|
| Geography | 3 | 2016 | 38 | 0.090 |
Why?
|
| Empyema | 1 | 2011 | 1 | 0.090 |
Why?
|
| Neoplasms | 1 | 2016 | 457 | 0.080 |
Why?
|
| Outpatients | 2 | 2012 | 103 | 0.080 |
Why?
|
| Public Health Surveillance | 2 | 2022 | 42 | 0.080 |
Why?
|
| Acute Disease | 3 | 2018 | 147 | 0.080 |
Why?
|
| Aging | 1 | 2012 | 159 | 0.080 |
Why?
|
| Peptic Ulcer | 1 | 2010 | 14 | 0.080 |
Why?
|
| Disability Evaluation | 1 | 2010 | 45 | 0.080 |
Why?
|
| Neuropsychological Tests | 1 | 2010 | 48 | 0.080 |
Why?
|
| Survival Rate | 1 | 2010 | 252 | 0.080 |
Why?
|
| Bronchiectasis | 1 | 2010 | 7 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2005 | 135 | 0.080 |
Why?
|
| Mycobacterium Infections | 1 | 2009 | 1 | 0.080 |
Why?
|
| Pregnancy | 4 | 2009 | 1565 | 0.080 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2009 | 7 | 0.080 |
Why?
|
| Staphylococcal Infections | 1 | 2009 | 15 | 0.080 |
Why?
|
| California | 3 | 2013 | 2433 | 0.080 |
Why?
|
| Infant, Low Birth Weight | 2 | 2007 | 30 | 0.080 |
Why?
|
| Utilization Review | 3 | 2008 | 42 | 0.080 |
Why?
|
| Models, Economic | 1 | 2009 | 17 | 0.080 |
Why?
|
| Health Policy | 1 | 2010 | 106 | 0.070 |
Why?
|
| Public Health | 1 | 1989 | 84 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 302 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 2 | 2007 | 237 | 0.070 |
Why?
|
| Equipment and Supplies | 1 | 2008 | 3 | 0.070 |
Why?
|
| ROC Curve | 1 | 2008 | 73 | 0.070 |
Why?
|
| Bronchiolitis, Viral | 1 | 2007 | 1 | 0.070 |
Why?
|
| Ischemic Attack, Transient | 1 | 2008 | 26 | 0.070 |
Why?
|
| Socioeconomic Factors | 4 | 2016 | 603 | 0.070 |
Why?
|
| Animals | 3 | 2018 | 285 | 0.070 |
Why?
|
| Infant, Premature, Diseases | 1 | 2007 | 16 | 0.070 |
Why?
|
| Whooping Cough | 1 | 2008 | 65 | 0.060 |
Why?
|
| History, 21st Century | 2 | 2019 | 22 | 0.060 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2006 | 2 | 0.060 |
Why?
|
| Infant, Premature | 1 | 2007 | 59 | 0.060 |
Why?
|
| Pneumonia, Viral | 1 | 2007 | 56 | 0.060 |
Why?
|
| Public Policy | 1 | 2006 | 14 | 0.060 |
Why?
|
| Diarrhea, Infantile | 1 | 2006 | 1 | 0.060 |
Why?
|
| Medical Records Department, Hospital | 1 | 2006 | 1 | 0.060 |
Why?
|
| United States Agency for Healthcare Research and Quality | 2 | 2005 | 10 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2019 | 214 | 0.060 |
Why?
|
| Mumps | 2 | 1997 | 13 | 0.060 |
Why?
|
| Mass Screening | 2 | 2005 | 693 | 0.060 |
Why?
|
| Costs and Cost Analysis | 1 | 2006 | 65 | 0.060 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2006 | 67 | 0.060 |
Why?
|
| Anti-Obesity Agents | 1 | 2005 | 18 | 0.060 |
Why?
|
| Drug Costs | 1 | 2005 | 32 | 0.060 |
Why?
|
| Spatio-Temporal Analysis | 2 | 2015 | 2 | 0.060 |
Why?
|
| Climate | 2 | 2015 | 3 | 0.060 |
Why?
|
| Obstetric Labor Complications | 1 | 2005 | 11 | 0.060 |
Why?
|
| Immunization Programs | 3 | 2016 | 64 | 0.060 |
Why?
|
| Elective Surgical Procedures | 1 | 2005 | 10 | 0.060 |
Why?
|
| Emergencies | 2 | 2010 | 6 | 0.060 |
Why?
|
| Cesarean Section | 1 | 2005 | 35 | 0.060 |
Why?
|
| Multiple Trauma | 1 | 2004 | 2 | 0.060 |
Why?
|
| Qualitative Research | 1 | 2026 | 290 | 0.050 |
Why?
|
| Evidence-Based Medicine | 2 | 2008 | 173 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 18 | 0.050 |
Why?
|
| Syndrome | 1 | 2004 | 28 | 0.050 |
Why?
|
| Radiography | 1 | 2004 | 36 | 0.050 |
Why?
|
| Pedigree | 1 | 2004 | 65 | 0.050 |
Why?
|
| Surveys and Questionnaires | 3 | 1997 | 1296 | 0.050 |
Why?
|
| Women's Health | 1 | 2005 | 198 | 0.050 |
Why?
|
| Likelihood Functions | 2 | 2015 | 45 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2004 | 107 | 0.050 |
Why?
|
| Prognosis | 2 | 2017 | 609 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2019 | 197 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2003 | 43 | 0.050 |
Why?
|
| Thrombosis | 1 | 2022 | 14 | 0.050 |
Why?
|
| Hospital Planning | 1 | 2002 | 1 | 0.050 |
Why?
|
| Insurance, Hospitalization | 1 | 2002 | 1 | 0.050 |
Why?
|
| Thromboembolism | 1 | 2022 | 32 | 0.050 |
Why?
|
| Interinstitutional Relations | 1 | 2002 | 12 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2001 | 686 | 0.050 |
Why?
|
| Uterine Hemorrhage | 1 | 2002 | 9 | 0.050 |
Why?
|
| Premenopause | 1 | 2002 | 24 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2002 | 50 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2002 | 38 | 0.040 |
Why?
|
| Mastectomy, Simple | 1 | 2001 | 1 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2002 | 87 | 0.040 |
Why?
|
| Mastectomy, Segmental | 1 | 2001 | 21 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 2 | 2017 | 124 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2002 | 73 | 0.040 |
Why?
|
| Public Health Administration | 1 | 2001 | 6 | 0.040 |
Why?
|
| Infant Mortality | 1 | 2001 | 15 | 0.040 |
Why?
|
| Maternal Health Services | 1 | 2001 | 11 | 0.040 |
Why?
|
| Endarterectomy, Carotid | 1 | 2000 | 5 | 0.040 |
Why?
|
| Information Services | 1 | 2000 | 12 | 0.040 |
Why?
|
| Publishing | 1 | 2000 | 9 | 0.040 |
Why?
|
| Health Services Misuse | 2 | 2016 | 12 | 0.040 |
Why?
|
| Ethnic Groups | 2 | 2016 | 443 | 0.040 |
Why?
|
| Mumps Vaccine | 2 | 1997 | 7 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2000 | 121 | 0.040 |
Why?
|
| Health Maintenance Organizations | 1 | 2001 | 403 | 0.040 |
Why?
|
| Vaccines, Attenuated | 2 | 2010 | 44 | 0.040 |
Why?
|
| State Health Plans | 1 | 1999 | 32 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2019 | 57 | 0.040 |
Why?
|
| Least-Squares Analysis | 2 | 2010 | 13 | 0.040 |
Why?
|
| Catheter-Related Infections | 1 | 2019 | 3 | 0.040 |
Why?
|
| Ape Diseases | 1 | 1999 | 1 | 0.040 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 1999 | 2 | 0.040 |
Why?
|
| Hawaii | 2 | 2010 | 62 | 0.040 |
Why?
|
| Florida | 1 | 1999 | 7 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2018 | 1 | 0.040 |
Why?
|
| Swine | 1 | 2018 | 5 | 0.040 |
Why?
|
| Urinary Tract Infections | 1 | 2019 | 18 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 11 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2018 | 9 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2018 | 14 | 0.040 |
Why?
|
| Colon | 1 | 2018 | 20 | 0.040 |
Why?
|
| Massachusetts | 1 | 1999 | 59 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2018 | 33 | 0.040 |
Why?
|
| Financing, Personal | 1 | 1999 | 18 | 0.040 |
Why?
|
| Direct Service Costs | 1 | 2018 | 8 | 0.040 |
Why?
|
| Child Health Services | 1 | 1999 | 107 | 0.040 |
Why?
|
| Information Seeking Behavior | 1 | 2018 | 11 | 0.030 |
Why?
|
| Mexico | 1 | 2018 | 18 | 0.030 |
Why?
|
| United Kingdom | 1 | 2018 | 25 | 0.030 |
Why?
|
| Poisson Distribution | 2 | 2010 | 85 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 1998 | 69 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2010 | 144 | 0.030 |
Why?
|
| Rubella Vaccine | 1 | 1997 | 9 | 0.030 |
Why?
|
| Measles Vaccine | 1 | 1997 | 17 | 0.030 |
Why?
|
| Vaginal Smears | 2 | 2005 | 48 | 0.030 |
Why?
|
| Protective Factors | 1 | 2017 | 32 | 0.030 |
Why?
|
| Tobacco Products | 1 | 2016 | 13 | 0.030 |
Why?
|
| Taxes | 1 | 2016 | 23 | 0.030 |
Why?
|
| New York | 2 | 2009 | 17 | 0.030 |
Why?
|
| Nurses | 1 | 2016 | 33 | 0.030 |
Why?
|
| Immunization, Secondary | 1 | 2016 | 58 | 0.030 |
Why?
|
| Algorithms | 1 | 1998 | 227 | 0.030 |
Why?
|
| Orthomyxoviridae | 1 | 2015 | 5 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 1996 | 36 | 0.030 |
Why?
|
| Osteoarthritis, Hip | 1 | 2015 | 8 | 0.030 |
Why?
|
| Osteoarthritis, Knee | 1 | 2015 | 11 | 0.030 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2015 | 3 | 0.030 |
Why?
|
| Humidity | 1 | 2015 | 2 | 0.030 |
Why?
|
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2015 | 15 | 0.030 |
Why?
|
| Temperature | 1 | 2015 | 17 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2015 | 37 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2015 | 90 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2014 | 9 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2015 | 67 | 0.030 |
Why?
|
| HIV Infections | 2 | 2013 | 584 | 0.030 |
Why?
|
| Germany | 1 | 2013 | 13 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2013 | 8 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2013 | 9 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2013 | 13 | 0.030 |
Why?
|
| Hospital Bed Capacity | 2 | 2003 | 5 | 0.020 |
Why?
|
| Streptococcus pneumoniae | 1 | 2013 | 20 | 0.020 |
Why?
|
| Reference Values | 1 | 2013 | 86 | 0.020 |
Why?
|
| Hospitals, Teaching | 2 | 2003 | 18 | 0.020 |
Why?
|
| Anxiety | 1 | 2014 | 162 | 0.020 |
Why?
|
| Parents | 1 | 2016 | 301 | 0.020 |
Why?
|
| Coinfection | 1 | 2013 | 23 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2015 | 256 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 56 | 0.020 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2013 | 21 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2014 | 248 | 0.020 |
Why?
|
| Mass Vaccination | 1 | 2012 | 22 | 0.020 |
Why?
|
| Bronchiolitis | 1 | 2012 | 5 | 0.020 |
Why?
|
| Insurance Selection Bias | 1 | 2012 | 2 | 0.020 |
Why?
|
| Models, Econometric | 1 | 2012 | 9 | 0.020 |
Why?
|
| Measles | 1 | 2012 | 24 | 0.020 |
Why?
|
| Minority Groups | 1 | 2012 | 104 | 0.020 |
Why?
|
| Registries | 2 | 2005 | 475 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2011 | 95 | 0.020 |
Why?
|
| Helicobacter Infections | 1 | 2010 | 22 | 0.020 |
Why?
|
| Helicobacter pylori | 1 | 2010 | 24 | 0.020 |
Why?
|
| Emergency Medicine | 1 | 2010 | 5 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 1251 | 0.020 |
Why?
|
| Immunity, Herd | 1 | 2009 | 4 | 0.020 |
Why?
|
| Birth Rate | 1 | 2009 | 3 | 0.020 |
Why?
|
| Southeastern United States | 1 | 1989 | 9 | 0.020 |
Why?
|
| Quality Control | 1 | 1989 | 40 | 0.020 |
Why?
|
| Laboratories | 1 | 1989 | 19 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2009 | 40 | 0.020 |
Why?
|
| Papanicolaou Test | 1 | 1989 | 38 | 0.020 |
Why?
|
| Specimen Handling | 1 | 1989 | 25 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 1989 | 120 | 0.020 |
Why?
|
| Population Dynamics | 1 | 2008 | 7 | 0.020 |
Why?
|
| Health Planning | 1 | 2008 | 16 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2009 | 171 | 0.020 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2008 | 96 | 0.020 |
Why?
|
| Insurance Carriers | 1 | 2007 | 6 | 0.020 |
Why?
|
| Patient Transfer | 1 | 2007 | 25 | 0.020 |
Why?
|
| Forms and Records Control | 1 | 2006 | 7 | 0.020 |
Why?
|
| Switzerland | 2 | 1997 | 4 | 0.020 |
Why?
|
| Rural Population | 1 | 2006 | 58 | 0.020 |
Why?
|
| Premature Birth | 1 | 2007 | 136 | 0.010 |
Why?
|
| Appetite Depressants | 1 | 2005 | 15 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 46 | 0.010 |
Why?
|
| Annual Reports as Topic | 1 | 2005 | 1 | 0.010 |
Why?
|
| Maternal Mortality | 1 | 2005 | 3 | 0.010 |
Why?
|
| Maternal Welfare | 1 | 2005 | 12 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 2004 | 9 | 0.010 |
Why?
|
| Income | 1 | 2005 | 86 | 0.010 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2005 | 70 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2005 | 50 | 0.010 |
Why?
|
| Odds Ratio | 2 | 1996 | 631 | 0.010 |
Why?
|
| Prenatal Care | 1 | 2005 | 129 | 0.010 |
Why?
|
| Mammography | 1 | 2005 | 173 | 0.010 |
Why?
|
| Suicide | 1 | 2005 | 116 | 0.010 |
Why?
|
| Continental Population Groups | 1 | 2005 | 283 | 0.010 |
Why?
|
| Nursing Staff, Hospital | 1 | 2003 | 10 | 0.010 |
Why?
|
| Ownership | 1 | 2003 | 13 | 0.010 |
Why?
|
| Patient-Centered Care | 1 | 2005 | 190 | 0.010 |
Why?
|
| Medical Futility | 1 | 2002 | 1 | 0.010 |
Why?
|
| Health Care Sector | 1 | 2002 | 1 | 0.010 |
Why?
|
| New Jersey | 1 | 2002 | 4 | 0.010 |
Why?
|
| Reimbursement, Incentive | 1 | 2002 | 21 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 2005 | 208 | 0.010 |
Why?
|
| Efficiency, Organizational | 1 | 2002 | 26 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2000 | 26 | 0.010 |
Why?
|
| Animals, Wild | 1 | 1999 | 1 | 0.010 |
Why?
|
| Disease Reservoirs | 1 | 1999 | 1 | 0.010 |
Why?
|
| Cote d'Ivoire | 1 | 1999 | 1 | 0.010 |
Why?
|
| Ecosystem | 1 | 1999 | 4 | 0.010 |
Why?
|
| Spleen | 1 | 1999 | 4 | 0.010 |
Why?
|
| Epidemiologic Factors | 1 | 1999 | 3 | 0.010 |
Why?
|
| Liver | 1 | 1999 | 31 | 0.010 |
Why?
|
| Program Evaluation | 1 | 1999 | 214 | 0.010 |
Why?
|
| Mumps virus | 1 | 1997 | 2 | 0.010 |
Why?
|
| Vaccines, Combined | 1 | 1997 | 81 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1998 | 363 | 0.010 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 1997 | 64 | 0.010 |
Why?
|
| Awareness | 1 | 1996 | 17 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1997 | 1107 | 0.010 |
Why?
|
| Varicose Veins | 1 | 1948 | 1 | 0.000 |
Why?
|
| Iodine Compounds | 1 | 1948 | 1 | 0.000 |
Why?
|
| Iodine | 1 | 1948 | 3 | 0.000 |
Why?
|